<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e> contributes to excess cardiovascular risk in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>There is strong evidence of an association between high serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> concentrations and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and <z:chebi fb="3" ids="27226">uric acid</z:chebi> has been proposed as an independent <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesised that lowering of <z:chebi fb="3" ids="27226">uric acid</z:chebi> concentrations might allow restoration of endothelial function in this high-risk group </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Intravenous urate oxidase (1.5 mg) was administered to ten patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and ten healthy participants in a two-way, randomised, placebo-controlled, crossover study </plain></SENT>
<SENT sid="4" pm="."><plain>Forearm blood flow responses to intra-brachial <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>, <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> and N(G)-monomethyl-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (<z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) were measured using venous occlusion plethysmography </plain></SENT>
<SENT sid="5" pm="."><plain>The augmentation index (AIx) was determined by pulse wave analysis as a measure of large arterial stiffness </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="9" ids="15355">Acetylcholine</z:chebi> and <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> evoked lesser responses in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than in healthy participants </plain></SENT>
<SENT sid="7" pm="."><plain>Baseline AIx was higher in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (mean +/- SD: 13.1 +/- 6.9%) than in healthy participants (2.0 +/- 5.1%; p = 0.006) </plain></SENT>
<SENT sid="8" pm="."><plain>Urate oxidase lowered serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> concentrations by 64 +/- 11% (p &lt; 0.001), but this had no effect on forearm blood flow responses or AIx in either group </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Substantial short-term lowering of <z:chebi fb="3" ids="27226">uric acid</z:chebi> did not have a direct vascular effect, suggesting that, on its own, this might not be an effective strategy for restoring endothelial function in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>